Eye test may help diagnose ADHD

Article

A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.

Tel Aviv, Israel-A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.

Share this pediatric vision checklist with your patients

Currently, doctors diagnose patients with ADHD through medical, behavioral, and social history of both the patient and the family because there are no reliable physiological markers to diagnose the disorder.

But researchers in Tel Aviv saw increased microsaccades and blink rates in adults with ADHD. The study found that there is a direct correlation between ADGD and the inability to suppress eye movement in the anticipation of visual stimuli. The research also found improved performance by the participants after taking methylphenidate, which normalized the suppression of the involuntary eye movements to the average level of the control group.

"We had two objectives going into this research," said Dr. Moshe Fried. "The first was to provide a new diagnostic tool for ADHD, and the second was to test whether ADHD medication really works-and we found that it does. There was a significant difference between the two groups, and between the two sets of tests taken by ADHD participants un-medicated and later medicated."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.